1. PROCUREMENT & DISTRIBUTION INTEREST GROUP Autumn Symposium 2007 http://www.pdig.org.uk/

2. Improving procurement in the NHS Chris Theaker Director, Pharmaceuticals 8 November 2007

3. Improving procurement in the NHS collaborative procurement avoiding litigation third party suppliers

4. Collaborative procurement collaborative procurement developments working with pharmacists Joint Category Working Group information systems

5. Collaborative procurement NHS PASA and Commercial Directorate NPSG role collaborative procurement hubs

6. Building capacity and capability in the NHS - CPHs all SHAs to have a hub available for every NHS Trust by March 2008 8 passed business case stage and are either fully mobilised or in the process of mobilisation South West business case finalised and under review London (LPP) developing its strategic sourcing model

7. 5 6 6 7 6 10 5 5 2 2 2 4 4 3 3 1 3 1 9 8 8 9 1.North East 2.North West 3.Yorkshire & the Humber 4.East Midlands 5.West Midlands 6.East of England 7.London 8.South East Coast 9.South Central 10.South West CPH roll out status by SHA – October 2007 Mobilised pre-April 2007:  North West CPH  West Midlands (HPC)  East Midlands (re:source)  South Central (PRO-CURE) Mobilised from April 2007:  East of England  South East Coast  Yorkshire and the Humber  North East (PRO-NE) CPH opportunity assessment:  South West – CPH business case proposal Sept 2007 Strategic sourcing opportunity assessment phase 2:  London – London Procurement Programme (LPP)

8. Collaborative procurement hubs deliver £270 million savings by 2007 improved support for clinicians and clinical networks by increasing their involvement in purchasing reduced clinical risk and enhanced patient safety strategies stronger partnerships with suppliers through commitment to contracts and a focused route into the health economy encouragement for innovation and provision of support for R&D in emerging treatments and technologies building a robust, sustainable environment for procurement specialists through improved career structure and enhanced recruitment and retention category focus – building capacity and capability to address complex categories and procurements e.g. mental health service, as well as traditional commodities

9. National strategy strategic framework to source pharmaceuticals 2005 terms of reference roles of NPSG, PMSG links with hubs

10. National strategy role of regional groups national sourcing (SCEP) pharmaceutical products and services

11. Terms of reference of JCWG strategic procurement issues inform procurement strategies share workplans commercial policy

12. Pharmaceutical products and services list (1) developed via discussion with pharmacists and procurement colleagues supports strategic framework 2005 defines category purchasing levels sourcing role/pharmaceutical input

13. Pharmaceutical products and services list (2) national CPH trust NHSSC

14. Pharmaceutical products and services list (3) clotting factors homecare services medical gases IV fluids branded medicines wholesaler agreements X-ray contrast media bulk disinfectants

15. Other aspects of collaboration information exchange terms and conditions stakeholder communication relations with industry training and development data

16. Sustainable procurement stakeholder workshop – October 2007 sustainable procurement action plan consultation / discussion

17. Information systems Pharmacy Business Technology Group NHS Procurement eEnablement Group UKPMS Coding for success GS1 Healthcare UK Group

18. Information systems - PharmEx activity reporting procurement information uptake patient safety information reporting / relationships with DH quality control

19. Collaborative procurement - summary national framework consistency regional flexibility local input future developments

20. Avoiding litigation NHS PASA procedures clarity and information meeting trade organisations good practice guidelines supplier briefings

21. Access to contracts (1) current approach market development trade bodies discussion at NPSG discussion with providers

22. Access to contracts (2) visibility of data role of PharmEx clarity of definition of NHS patients procedures and processes

23. Access to contracts – checklist NHS patients secondary care access availability of data supply arrangements

24. Access to contracts – next steps continuing dialogue industry input NPSG report agreement of a policy document

25. Summary pharmacists’ key role national / regional strategies dialogue with suppliers procurement collaboration flexible approach

26. Questions Chris Theaker Director, Pharmaceuticals chris.theaker@pasa.nhs.uk